Results 41 to 50 of about 100,300 (318)

Drug-Coated Balloon vs. Drug-Eluting Stent in Acute Myocardial Infarction: A Systematic Review and Updated Meta-Analysis

open access: yesAnatolian Journal of Cardiology, 2023
Background: This study aimed to systematically review the evidence of drug-coated balloon used in the treatment of acute myocardial infarction and compared with using drug-eluting stent in terms of clinical and angiographic outcomes for a relatively long
Zhen Fang   +4 more
doaj   +1 more source

Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. [PDF]

open access: yes, 2014
peer reviewedOBJECTIVE: To investigate whether revascularisation improves prognosis compared with medical treatment among patients with stable coronary artery disease.
Alfonso, Fernando   +34 more
core   +4 more sources

Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge

open access: yesEuropean Heart Journal - Cardiovascular Pharmacotherapy, 2018
The recognition that obstructive disease of the epicardial coronary arteries, causing ischaemic heart disease, can be treated with a percutaneous coronary intervention (PCI) has been a major discovery in cardiology in the last 40 years contributing, in ...
J. Borovac   +10 more
semanticscholar   +1 more source

Comparison of Long‐Term Clinical Outcomes of Lesions Exhibiting Focal and Segmental Peri‐Stent Contrast Staining

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundPeri‐stent contrast staining (PSS) after metallic drug‐eluting stent deployment is associated with target lesion revascularization and very late stent thrombosis.
Takahiro Tokuda   +14 more
doaj   +1 more source

Safety and efficacy of biodegradable polymer-coated biolimus-eluting stents

open access: yesThe Egyptian Heart Journal, 2013
Background: Using drug eluting stents with a biodegradable polymer ensures that both the drug and coating are absorbed from the stent surface after completing their functions, which may reduce the need for prolonged antiplatelet therapy and decrease the ...
Walid Maamoun
doaj   +1 more source

Drug Distribution and Stent Retention of Drug Eluting Stents [PDF]

open access: yes, 2008
In this paper the examinations of drug eluting coronary stents are shown, such as the morphology of the coatings before expansion, drug distribution, the methodology and the value of stent retention.
Balázs, T.   +3 more
core  

Cell Calcification Models and Their Implications for Medicine and Biomaterial Research

open access: yesAdvanced Healthcare Materials, EarlyView.
Calcification, is the process by which the tissues containing minerals are formed, occurring during normal physiological processes, or in pathological conditions. Here, it is aimed to give a comprehensive overview of the range of cell models available, and the approaches taken by these models, highlighting when and how methodological divergences arise,
Luke Hunter   +5 more
wiley   +1 more source

An Unusual Migration of A Stent: A Case Report

open access: yesMarshall Journal of Medicine, 2016
Stent dislodgment and embolization is a rare complication of coronary stenting. There are reports of intra-coronary stent entrapment, stripping, and dislodgement during percutaneous coronary interventions causing potentially life threatening ...
Melissa D. Lester   +3 more
doaj   +1 more source

In Stent Restenosis After Drug-Eluting Stent Implantation in a Patient with Polycythemia Vera: A Case Report

open access: yesJournal of Agromedicine and Medical Sciences (AMS), 2023
Polycythemia vera happened in people around 40-60 years old and mostly men. The criteria are total red blood cells ≥36 mL/kg in males, thrombocytosis, leukocytosis, and JAK2 mutation.
I Gusti Ayu Ratna Dewi   +2 more
doaj   +1 more source

Drug-eluting stents: current issues [PDF]

open access: yes, 2005
Early stent thrombosis occurs in about 1% to 1.5% of patients with drug-eluting stents, very similar to the rate with bare-metal stents. Late stent thrombosis is more of a concern with drug-eluting stents, with an incidence of at least 0.35%.
Ong, A.T.L. (Andrew)   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy